Literature DB >> 27193608

Hypoxia Augments Increased HIF-1α and Reduced Survival Protein p-Akt in Gelsolin (GSN)-Dependent Cardiomyoblast Cell Apoptosis.

Yu-Lan Yeh1,2, Wei-Jen Ting3, Chia-Yao Shen4, Hsi-Hsien Hsu5, Li-Chin Chung6, Chuan-Chou Tu7, Sheng-Huang Chang8, Cecilia-Hsuan Day4, Yuhsin Tsai9, Chih-Yang Huang10,11,12.   

Abstract

Cytoskeleton filaments play an important role in cellular functions such as maintaining cell shape, cell motility, intracellular transport, and cell division. Actin-binding proteins (ABPs) have numerous functions including regulation of actin filament nucleation, elongation, severing, capping, cross linking, and actin monomer sequestration. Gelsolin (GSN) is one of the actin-binding proteins. Gelsolin (GSN) is one of the actin-binding proteins that regulate cell morphology, differentiation, movement, and apoptosis. GSN also regulates cell morphology, differentiation, movement, and apoptosis. In this study, we have used H9c2 cardiomyoblast cell and H9c2-GSN stable clones to understand the roles and mechanisms of GSN overexpression in hypoxia-induced cardiomyoblast cell death. The data show that hypoxia or GSN overexpression induces HIF-1α expression and reduces the expression of survival markers p-Akt and Bcl-2 in H9c2 cardiomyoblast cells. Under hypoxic conditions, GSN overexpression further reduces p-Akt expression and elevates total as well as cleaved GSN levels and HIF-1α levels. In addition, GSN overexpression enhances apoptosis in cardiomyoblasts under hypoxia. Hypoxic challenge further induced activated caspase-3 and cell death that was attenuated after GSN knock down, which implies that GSN is a critical therapeutic target against hypoxia-induced cardiomyoblast cell death.

Entities:  

Keywords:  Cardiomyoblast cell apoptosis; Gelsolin; HIF-1α; Hypoxia; p-Akt

Mesh:

Substances:

Year:  2016        PMID: 27193608     DOI: 10.1007/s12013-016-0729-6

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  6 in total

1.  Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma.

Authors:  Dylan Z Kelley; Emily L Flam; Theresa Guo; Ludmila V Danilova; Fernando T Zamuner; Craig Bohrson; Michael Considine; Eric J Windsor; Justin A Bishop; Chi Zhang; Wayne M Koch; David Sidransky; William H Westra; Christine H Chung; Joseph A Califano; Sarah Wheelan; Alexander V Favorov; Liliana Florea; Elana J Fertig; Daria A Gaykalova
Journal:  Transl Res       Date:  2018-07-26       Impact factor: 7.012

2.  Cross talk between 26S proteasome and mitochondria in human mesenchymal stem cells' ability to survive under hypoxia stress.

Authors:  Ramada R Khasawneh; Ejlal Abu-El-Rub; Abdullah Omar Serhan; Bashar Omar Serhan; Hadeel Abu-El-Rub
Journal:  J Physiol Sci       Date:  2019-11-02       Impact factor: 2.781

3.  Estrogen and/or Estrogen Receptor α Inhibits BNIP3-Induced Apoptosis and Autophagy in H9c2 Cardiomyoblast Cells.

Authors:  Bih-Cheng Chen; Yi-Jiun Weng; Marthandam Asokan Shibu; Chien-Kuo Han; Yueh-Sheng Chen; Chia-Yao Shen; Yueh-Min Lin; Vijaya Padma Viswanadha; Hsin-Yueh Liang; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

4.  Identification of aberrantly methylated differentially expressed genes targeted by differentially expressed miRNA in osteosarcoma.

Authors:  Ting-Xuan Wang; Wen-Le Tan; Jin-Cheng Huang; Zhi-Fei Cui; Ri-Dong Liang; Qing-Chu Li; Hai Lu
Journal:  Ann Transl Med       Date:  2020-03

5.  MicroRNA-30c-5p ameliorates hypoxia-reoxygenation-induced tubular epithelial cell injury via HIF1α stabilization by targeting SOCS3.

Authors:  Yan-Fang Zou; Wei-Tang Liao; Zong-Jie Fu; Qian Zhao; Yong-Xi Chen; Wen Zhang
Journal:  Oncotarget       Date:  2017-10-06

6.  Quantitative Proteomic Analysis of 2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced Proteome.

Authors:  Young Eun Kim; Hyo Jin Jeon; Dahee Kim; Sun Young Lee; Ki Young Kim; Jongki Hong; Pil Jae Maeng; Kwang-Rok Kim; Dukjin Kang
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.